Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-15 Vitale Nancy Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2020-06-04 PIERCE GLENN Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-06-04 Higgins Michael J Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-06-04 Hyman Steven Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-06-04 GERAGHTY JAMES A Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-06-04 DIXON WENDY L Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-06-04 PAUL STEVEN M Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-06-04 LEVIN MARK J Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-05-21 Khwaja Omar Sale −3,500 $12.96 $45K 56,500
2020-04-03 Hesslein Robert W. Senior VP & General Counsel Sale −3,091 $8.51 $26K 52,534
2020-02-10 Dorval Allison Chief Financial Officer Grant or award +27,500 52,022
2020-02-10 Dorval Allison Chief Financial Officer Grant or award · Stock Option (Right to Buy) +55,000 55,000
2020-02-10 Hesslein Robert W. Senior VP & General Counsel Grant or award +27,500 55,625
2020-02-10 Hesslein Robert W. Senior VP & General Counsel Grant or award · Stock Option (Right to Buy) +55,000 55,000
2020-02-10 Khwaja Omar Grant or award +30,000 60,000
2020-02-10 Khwaja Omar Grant or award · Stock Option (Right to Buy) +60,000 60,000
2020-02-10 Turenne Andre President & CEO Grant or award +81,250 166,795
2020-02-10 Turenne Andre President & CEO Grant or award · Stock Option (Right to Buy) +162,500 162,500
2020-01-21 Dorval Allison Chief Financial Officer Sale −3,128 $13.36 $42K 24,522
2020-01-21 Ottmer Matthew P. Chief Operating Officer Sale −3,724 $13.36 $50K 26,276

Page 13 of 19 · 368 trades